Neuroendocrine tumours trials in Austria

4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

  Where

  Graz, Vienna

  Age

  18 years and over

  People

  390 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT07544654 · EU 2025-523869-22-00
• Phase 2/3Taking people
  Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

  Where

  Graz, Salzburg, Vienna

  Age

  18 years and over

  People

  440 worldwide

  Run by

  Exelixis

  See details and how to joinNCT06943755 · EU 2025-521043-20-00
• No phaseTaking people
  Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment

  Where

  Graz, Linz, Vienna

  Age

  18 years and over

  People

  150 worldwide

  Run by

  Ipsen

  See details and how to joinNCT07314164
• Phase 3Taking people
  Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide versus Durvalumab, Carboplatin, and Etoposide in First-Line ES-SCLC (DeLLphi-312)

  Where

  Graz, Krems An Der Donau

  Age

  18 years and over

  People

  156 worldwide

  Run by

  Amgen Inc.

  See details and how to join2024-520050-38-00 · EU 2024-520050-38-00